The marketing research of the level of promoting the rational use of medicines by pharmacists in Ukraine

uk.

Authors

DOI:

https://doi.org/10.24959/sphhcj.21.207

Abstract

Aim. To conduct the marketing analysis of the frequency and causes of the irrational use of medicines according to the assessment of the Ukrainian pharmacists, participation of pharmacists in promoting the rational use of drugs, and identifying appropriate measures to improve the situation.

Materials and methods. To achieve this goal, a survey of pharmacists from different regions of Ukraine was conducted, 420 questionnaires were selected and processed.

Results. According to pharmacists, such types of the irrational use of drugs as false self-medication, polypharmacy, and the use of expensive drugs in the presence of cheaper alternatives are the most common in Ukraine. The most important reasons for this phenomenon are uncontrolled self-medication, the impact of advertising and the availability of many over-the-counter medicines. The Ukrainian pharmacists take certain measures to influence on the rational use of drugs: refusal to dispense medicines, supplement to the doctor’s prescription, correction of the duration of treatment, and others. When counseling pharmacy visitors the largest number of respondents provide information on the way, frequency and duration of taking a medication, the smallest part – recommendations for a healthy lifestyle or non-pharmacological recommendations for the treatment. The respondents consider compliance with the rules of dispensing prescription medicines, training and advanced training of pharmacists throughout their professional career, and limitation of excessive advertising of medicines as the most appropriate measures to promote the rational use of medicines.

Conclusions. The results of the research reflect the peculiarities of the Ukrainian pharmacy practice regarding the participation of pharmacists in promoting the rational use of medicines.

Key words: rational use of medicines; pharmaceutical care; pharmaceutical consulting; good pharmacy practice.

Author Biographies

S. V. Zhadko, National University of Pharmacy

Candidate of Pharmacy (Ph.D.), associate professor of the Pharmaceutical Management and Marketing Department

I. V. Pestun, National university of pharmacy

Doctor of Pharmacy (Dr. habil.), professor of the Pharmaceutical Management and Marketing Department

N. P. Zavadska, Zhytomyr Basic Pharmaceutical Professional College

Teacher of the highest qualification category, teacher of pharmaceutical disciplines, Zhytomyr Basic Pharmaceutical Professional College

N. M. Senkiv, Zhytomyr Basic Pharmaceutical Professional College

Teacher of the highest qualification category, teacher of pharmaceutical disciplines

References

MOZ Ukrainy. (2013). Nakaz vid 30.05.2013 No. 455 “Pro zatverdzhennia nastanovy “Nalezhna aptechna praktyka: Standarty yakosti aptechnykh posluh”. zakon.rada.gov.ua. Available at: https://zakon.rada.gov.ua/rada/show/v0455282-13#Text.

MOZ Ukrainy. (2010). Nakaz vid 13.09.2010 No. 769 “Pro zatverdzhennia Kontseptsii rozvytku farmatsevtychnoho sektoru haluzi okhorony zdorovia Ukrainy na 2011–2020 roky”. zakon.rada.gov.ua. Available at: https://zakon.rada.gov.ua/rada/show/v0455282-13#Text.

MOZ Ukrainy. (2013). Nakaz vid 11.10.2013 No. 875 “Pro zatverdzhennia Protokoliv provizora (farmatsevta)”. Available at: https://zakon.rada.gov.ua/rada/show/v0875282-13#Text.

Sanii, Y., Torkamandi, H., Gholami, K., Hadavand, N., Javadi, M. (2016). Journal of Research in Pharmacy Practice, 5 (2), 1322–1337. DOI: https://doi.org/10.4103/2279-042X.179580.

Sakeena, M. H. F., Bennett, A. A., McLachlan, A. J. (2018). Enhancing pharmacists’ role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review. Antimicrobial Resistance and Infection Control, 7 (63). doi: https://doi.org/10.1186/s13756-018-0351-z.

Kotwani, A., Watta, C., Joshi, P. C., Holloway, K. (2012). Irrational use of antibiotics and role of the pharmacist: an insight from a qualitative study in New Delhi, India Journal of Clinical Pharmacy and Therapeutist, 37 (3), 308–312.

Chisholm-Burns, M. A., Kim Lee, J., Spivey, C.A., Slack, M., Herrier, R. N., Hall-Lipsy, E., Graff Zivin, J., Abraham, I., Palmer, J., Martin J. R., Kramer, S.S., Wunz, T. (2010). US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Medical Care, 48 (10), 923–933. doi: https://doi.org/10.1097/MLR.0b013e3181e57962.

Khaira, M., Mathers, A., Gerard, N. B., Dolovich, L. (2020). The Evolving Role and Impact of Integrating Pharmacists into Primary Care Teams: Experience from Ontario, Canada. Pharmacy (Basel), 8 (4), 234. DOI: https://doi.org/10.3390/pharmacy8040234.

Akerman, M., Freitas, O. (2017). National Survey on Access, Use and Promotion of Rational Use of Medicines (PNAUM): evaluation of pharmaceutical services in the primary health care. Revista de Saúde Pública, 51 (2). doi: https://doi.org/10.11606/S1518-8787.201705100supl2ed.

Pestun, Y. V. (2010). Teoretychni ta naukovo-prykladni zasady marketynhovoho upravlinnia v systemi likarskoho zabezpechennia naselennia. Thesis abstract of Doctor of Science. Kharkiv.

Nemchenko, A. S., Kotvitska, A. A., Surikov, O. O. (2005). Farmatsevtychnyi zhurnal, 4, 22–28.

Zhadko, S. V., Pestun, Y. V. (2018). Retsept, 21 (2), 211–219.

Tereshchenko, L. V. (2015). Naukove obgruntuvannia pryntsypiv derzhavnoho rehuliuvannia retsepturnoho ta bezretsepturnoho vidpusku likarskykh zasobiv v Ukraini. PhD thesis abstract. Kharkiv.

Hutorova, N. (2019). Shchotyzhnevyk “Apteka”, 14 (1185). Available at: https://www.apteka.ua/article/497652.

Bodnarchuk, I. (2020). Shchotyzhnevyk “Apteka”, 27/28 (1248/1249). Available at: https://www.apteka.ua/article/555429.

Mnushko, Z. M., Alekperova, N. V., Pestun, I. V., Babicheva, H. S. (2012). Visnyk farmatsii. 4, 57–61.

Ferreri, S. P., Hughes, T. D., Snyder, M. E. (2020). Medication Therapy Management: Current Challenges. Integr Pharm Res Pract, 9, 71–81. doi: https://doi.org/10.2147/IPRP.S179628.

Chen, T. F. (2016). Pharmacist-Led Home Medicines Review and Residential Medication Management Review: The Australian Model. Drugs Aging, 33 (3), 199–204. doi: https://doi.org/10.1007/s40266-016-0357-2.

Shimp, L. A., Kucukarslan, S. N., Elder, J., Remington, T., Wells, T., Choe, H. M., Lewis, N. J., Kirking, D. M. (2012). Employer-based patient-centered medication therapy management program: evidence and recommendations for future programs. J Am Pharm Assoc., 52 (6), 768–776. doi: https://doi.org/10.1331/JAPhA.2012.11186.

Brummel, A., Lustig, A., Westrich, K., Evans, M. A., Plank, G. S., Penso, J., Dubois, R. W. (2014). Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management. J Manag Care Spec Pharm., 20 (12), 1152–1158. doi: https://doi.org/10.18553/jmcp.2014.20.12.1152.

Foppa, A. A, Chemello, C., Vargas-Peláez, C. M., Farias, M. R. (2016). Medication Therapy Management Service for Patients with Parkinson’s Disease: A Before-and-After Study. Neurol Ther., 5 (1), 85–99. doi: https://doi.org/10.1007/s40120-016-0046-4.

Theising, K. M., Fritschle, T. L., Scholfield, A. M., Hicks, E. L., Schymik, M. L. (2015). Implementation and Clinical Outcomes of an Employer-Sponsored, Pharmacist-Provided Medication Therapy Management Program. Pharmacotherapy, 35 (11), 159–163. doi: https://doi.org/10.1002/phar.1650.

Wyoming Pharmacy Act Rules and Regulations. Wyoming Pharmacy laws. Available at: https://pharmacyboard.wyo.gov/laws.

Published

2021-03-12

Issue

Section

Organizational and socio-economic bases of pharmaceutical activities